Location History:
- Port Jefferson, NY (US) (2002)
- New York, NY (US) (1998 - 2008)
- Albany, NY (US) (2021)
- Setauket, NY (US) (2011 - 2023)
Company Filing History:
10 out of 1,991 
1 out of 92 
1 out of 635 
Years Active: 1998-2023
Title: The Innovations of Steven S. Skiena: A Pioneer in Vaccine Development
Introduction: Steven S. Skiena, a renowned inventor based in New York, NY, has made significant contributions to the field of vaccine development. With a portfolio of 11 patents, his work has focused on creating innovative solutions for influenza viruses and vaccine methodologies that promise to enhance safety and efficacy.
Latest Patents: Among his latest patents are groundbreaking inventions in the realm of vaccine technology. One of his notable patents involves highly attenuated influenza viruses and vaccines. This invention provides a new approach to generating vaccines that not only proliferate effectively but also exhibit high safety factors, ensuring protective immunity against the same subtype of the virus, as well as offering cross-protective benefits against heterologous viruses. Additionally, he introduced compositions and methods for generating reversion-free attenuated and/or replication-incompetent vaccine vectors. This innovative method employs a codon-shuffled helper gene to produce compositions that are safe for use in vaccination processes and hold potential for future vaccine applications.
Career Highlights: Throughout his career, Skiena has worked with esteemed organizations such as the Research Foundation of the State University of New York. His experience in this research-intensive environment has allowed him to refine his skills and develop technologies that push the boundaries of current vaccine strategies.
Collaborations: Collaboration has played a vital role in Skiena's success. He has worked alongside distinguished colleagues such as Harald Rau and Namrata Godbole. Their combined expertise has propelled many of Skiena's innovations to fruition, resulting in patents that significantly contribute to medical science.
Conclusion: Steven S. Skiena's dedication to innovation in vaccine development underscores his position as a leading inventor in the field. His numerous patents reflect a commitment to advancing public health through safer and more effective vaccines. As research continues to evolve, Skiena's contributions pave the way for future breakthroughs in the fight against infectious diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.